CN110904002A - Method for biologically removing tetracycline antibiotics - Google Patents

Method for biologically removing tetracycline antibiotics Download PDF

Info

Publication number
CN110904002A
CN110904002A CN201911168281.0A CN201911168281A CN110904002A CN 110904002 A CN110904002 A CN 110904002A CN 201911168281 A CN201911168281 A CN 201911168281A CN 110904002 A CN110904002 A CN 110904002A
Authority
CN
China
Prior art keywords
seed
bacillus clausii
tetracycline antibiotics
bacillus
seeds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201911168281.0A
Other languages
Chinese (zh)
Other versions
CN110904002B (en
Inventor
程景胜
刘晓春
元英进
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin University
Original Assignee
Tianjin University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin University filed Critical Tianjin University
Priority to CN201911168281.0A priority Critical patent/CN110904002B/en
Publication of CN110904002A publication Critical patent/CN110904002A/en
Application granted granted Critical
Publication of CN110904002B publication Critical patent/CN110904002B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F3/00Biological treatment of water, waste water, or sewage
    • C02F3/34Biological treatment of water, waste water, or sewage characterised by the microorganisms used
    • C02F3/341Consortia of bacteria
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2101/00Nature of the contaminant
    • C02F2101/30Organic compounds
    • C02F2101/38Organic compounds containing nitrogen

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Water Supply & Treatment (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Environmental & Geological Engineering (AREA)
  • Hydrology & Water Resources (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention discloses a method for biologically removing tetracycline antibiotics, which comprises the following steps: (1) seed culture: culturing the secondary seeds of the bacillus clausii and the bacillus amyloliquefaciens; (2) removing: mixing water containing tetracycline antibiotics with fermentation medium to obtain degradation solution, inoculating Bacillus clausii secondary seed and HM-618 secondary seed into the degradation solution, and fermenting. The invention establishes a co-culture system of bacillus clausii and bacillus amyloliquefaciens, and adds the co-culture system into a water body containing tetracycline antibiotics, so that the bacillus amyloliquefaciens can produce surface active substances in situ to promote the biological removal of the tetracycline antibiotics, and a series of complicated steps such as separation and purification of a surfactant are omitted; the method not only improves the biological removal efficiency of the tetracycline antibiotics, but also obviously reduces the biological toxicity of the tetracycline antibiotic conversion products.

Description

Method for biologically removing tetracycline antibiotics
Technical Field
The invention belongs to the field of environmental remediation, and relates to a method for biologically removing tetracycline antibiotics by using a surfactant as an auxiliary agent.
Background
The tetracycline antibiotics represented by Oxytetracycline (OTC) and chlorotetracycline (CTC) are broad-spectrum antibiotics, are widely applied to animal husbandry and aquaculture, account for 14% of the total antibiotic usage, and are detected in different water body environments in China. It not only causes serious water pollution threatening the survival of aquatic plants, animals and microorganisms, but also causes the emergence of tetracycline resistance in bacteria and the spread of resistance genes, and thus the search for effective methods to remove tetracycline antibiotics from water bodies is imminent.
The traditional physical methods such as adsorption, photocatalysis and the like have high cost and are easy to cause secondary pollution. While biodegradation is reported in many documents as the most important way to remove tetracycline antibiotics, the current removal of tetracycline antibiotics is mostly dependent on microbial communities in the environment, or pure bacterial cultures concentrated on fungal species, and there are also a few strains identified with tetracycline antibiotic-degrading ability isolated, but the biological removal efficiency is not high, and the biological removal mechanism is still not well understood.
Surfactants are substances which can obviously reduce surface (interface) tension even at very low concentration, are widely applied to industries such as agriculture, food production, chemistry and chemical industry, medical pharmacy and the like at present, particularly to special fields such as petroleum industry, environmental engineering and the like, and can improve the bioavailability of organic pollutants through the processes of emulsification, pseudophase solubility improvement, microbial membrane degradation permeability enhancement, transportation promotion and the like.
At present, no report exists for removing tetracycline antibiotics by mixed fermentation of bacillus clausii and a surfactant-producing bacterium.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provide a method for biologically removing tetracycline antibiotics.
The technical scheme of the invention is summarized as follows:
a method for the biological removal of a tetracycline antibiotic comprising the steps of:
(1) seed culture: culturing Bacillus clausii Bacillus clausii T to obtain a first-stage Bacillus clausii seed; culturing the first-stage seeds of the bacillus clausii to obtain second-stage seeds of the bacillus clausii;
culturing Bacillus amyloliquefaciens HM-618, CGMCC7097, abbreviated as HM-618 to obtain first-grade seeds of HM-618; culturing the first-level seeds of HM-618 to obtain second-level seeds of HM-618;
(2) removing: adding 70-80mL of water containing tetracycline antibiotics into 20-30mL of fermentation medium according to a proportion to prepare degradation liquid; inoculating the secondary seed of the bacillus clausii obtained in the step (1) and the secondary seed of HM-618 into 100mL of degradation liquid to ensure that the total initial OD6000.15-0.23, wherein the initial inoculation ratio of the second-level seed of the Bacillus clausii to the second-level seed of the HM-618 is 1: 1; fermenting for 96-120h at the rotating speed of 200-220 rpm and the temperature of 36-38 ℃.
The formula of the fermentation medium is preferably as follows: 55-65g/L of glucose; 3-8g/L of yeast extract powder; 3-8g/L of peptone; 3-8g/L NaCl; KCl 0.3-0.8 g/L; k2HPO41-5 g/L;KH2PO41-5 g/L;MgSO4·7H2O 0.3-0.8g/L;FeSO4·7H2O(0.5-1.5)×10-3g/L;CuSO4·5H2O(0.5-1.5)×10-5g/L;MnSO4(5-8)×10-5g/L;ZnSO4·7H2O(0.5-1.5)×10-3g/L; the balance of water.
The tetracycline antibiotics are oxytetracycline and chlorotetracycline, and other tetracycline antibiotics can be selected.
The invention has the advantages that:
the invention establishes a co-culture system of bacillus clausii and bacillus amyloliquefaciens, and adds the co-culture system into a water body containing tetracycline antibiotics, so that the bacillus amyloliquefaciens can produce surface active substances in situ in fermentation liquor to promote the degradation of the tetracycline drugs, and a series of complicated steps such as separation and purification of a surfactant are omitted; the method not only improves the biological removal efficiency of the tetracycline antibiotics, but also obviously reduces the biological toxicity of the tetracycline antibiotic purification product.
Drawings
Figure 1 shows the removal rates for pure and co-cultured oxytetracycline.
Figure 2 is the biotoxicity of oxytetracycline conversion product.
Figure 3 shows the removal rate of chlorotetracycline for pure and co-cultures.
Figure 4 is the biotoxicity of the chlortetracycline conversion product.
In the above figures:
OTC represents oxytetracycline only and no bacteria;
t + OTC stands for b.clausii T pure culture to remove oxytetracycline;
HT + OTC stands for B.clausii T and HM-618 mixed culture (initial OD of two bacteria)600In a ratio of 1: 1) removing oxytetracycline;
CTC represents chloride tetracycline only, no bacteria;
t + CTC represents b.clausii T pure culture with removal of chlortetracycline;
HT + CTC stands for B.clausii T and HM-618 mixed culture (initial OD of two bacteria)600In a ratio of 1: 1) the chlortetracycline is removed.
Detailed Description
Bacillus clausii (b.clausii T) was purchased from: 2016. year 6, organization: sunofil (sanofi), country: italy, website: http:// www.sanofi.it/l/it/it/index
Bacillus amyloliquefaciens (Bacillus amyloliquefaciens) HM-618CGMCC NO.7097 is preserved in the common microorganism center of China Committee for culture Collection of microorganisms in 2013, 1 month and 8 days, No. 3 of No. 1 Xilu-Chen of the Chaoyang district, Beijing City, Microbiol research institute of Chinese academy of sciences, postal code 100101, telephone 010 plus 64807355, and survives.
The invention will be further illustrated with reference to specific examples:
example 1
The first seed culture medium, tryptone 10g/L, yeast extract 5g/L, NaCl 10g/L, the balance water.
A second seed culture medium, 60g/L of glucose, 10g/L of beef extract, 10g/L of peptone, 10g/L of yeast extract, 5g/L of NaCl and the balance of water.
Example 2
The formula of the fermentation medium is as follows: glucose 55 g/L; 8g/L of yeast extract powder; peptone 8 g/L; NaCl 8 g/L; KCl0.8g/L; k2HPO45 g/L;KH2PO45 g/L;MgSO4·7H2O 0.8g/L;FeSO4·7H2O 1.5×10-3g/L;CuSO4·5H2O 1.5×10-5g/L;MnSO48×10-5g/L;ZnSO4·7H2O 1.5×10-3g/L; the balance of water.
Example 3
The formula of the fermentation medium is as follows: glucose 65 g/L; 3g/L of yeast extract powder; 3g/L of peptone; NaCl3 g/L; KCl0.3g/L; k2HPO41 g/L;KH2PO41 g/L;MgSO4·7H2O 0.3g/L;FeSO4·7H2O 0.5×10-3g/L;CuSO4·5H2O 0.5×10-5g/L;MnSO45×10-5g/L;ZnSO4·7H2O 0.5×10-3g/L; the balance of water.
Example 4
A method for the biological removal of a tetracycline antibiotic comprising the steps of:
(1) seed culture: culturing bacillus clausii T in a first seed culture medium to obtain a first-stage bacillus clausii seed; culturing the first-stage seed of the bacillus clausii in a first seed culture medium to obtain a second-stage seed of the bacillus clausii;
culturing bacillus amyloliquefaciens B.amyloliquefaciens HM-618 abbreviated as HM-618 in a second seed culture medium to obtain HM-618 first-grade seeds; culturing the first-level seeds of HM-618 in a second seed culture medium to obtain second-level seeds of HM-618;
(2) removing: adding 80mL of water containing oxytetracycline with the concentration of 12.5mg/L into 20mL of the fermentation culture medium of the embodiment 2 to prepare degradation liquid; inoculating the secondary seed of the bacillus clausii obtained in the step (1) and the secondary seed of the HM618 into 100mL of degradation liquid to ensure that the total initial OD6000.15, Bacillus clausii IIThe initial inoculation ratio of the grade seeds and the HM-618 grade seeds is 1: 1; fermenting at the rotation speed of 220rpm and the temperature of 36 ℃ for 120 h.
Centrifuging at 12000rpm, collecting supernatant, and detecting oxytetracycline concentration in the supernatant by using a high performance liquid chromatograph.
Comparative example 1:
the second-order Bacillus clausii seed obtained in step (1) was used in place of the second-order Bacillus clausii seed and the second-order HM-618 seed of example 4, and the procedure was otherwise the same as in example 4.
The biological removal rate of the bacillus clausii in the control example 1 to oxytetracycline in the water body at 120h was 72%, and the biological removal rate of the bacillus clausii and HM-618 in the mixed culture at 120h was 77% (significance analysis p <0.01), as shown in fig. 1. The mixed culture of bacillus clausii and bacillus amyloliquefaciens of example 4 significantly reduced the biotoxicity of oxytetracycline conversion products in water, as shown in fig. 2.
Example 5
A method for the biological removal of a tetracycline antibiotic comprising the steps of:
(1) seed culture: culturing bacillus clausii T in a first seed culture medium to obtain a first-stage bacillus clausii seed; culturing the first-stage seed of the bacillus clausii in a first seed culture medium to obtain a second-stage seed of the bacillus clausii;
culturing the HM-618 in a second seed culture medium to obtain HM-618 first-grade seeds; culturing the first-level seeds of HM-618 in a second seed culture medium to obtain second-level seeds of HM-618;
(2) removing: adding 70mL of water containing chlortetracycline with the concentration of 12.5mg/L into 30mL of the fermentation medium of the embodiment 3 to prepare a degradation liquid; inoculating the secondary seed of the bacillus clausii obtained in the step (1) and the secondary seed of HM-618 into 100mL of degradation liquid to ensure that the total initial OD600Is 0.23, the initial inoculation ratio of the second-level seed of the Bacillus clausii to the second-level seed of the HM-618 is 1: 1; fermenting at the rotation speed of 200rpm and the temperature of 38 ℃ for 96 h.
Centrifuging at 12000rpm, collecting supernatant, and detecting the concentration of the chlortetracycline in the supernatant by using a high performance liquid chromatograph.
Comparative example 2:
the second-order Bacillus clausii seed obtained in step (1) was used in place of the second-order Bacillus clausii seed and the second-order HM-618 seed of example 5, and the procedure was otherwise the same as in example 5.
The mixed culture of the Bacillus clausii of comparative example 2 and the Bacillus clausii of example 5 with HM-618 completely removed the chlortetracycline in the water at 96h, as shown in FIG. 3. And the mixed culture of the bacillus clausii and the bacillus amyloliquefaciens in the example 5 obviously reduces the biotoxicity of the chlortetracycline conversion product in the water body, and the figure is 4.
The high performance liquid chromatography used a C18 column (250X 4.6mm,5 μm), a Waterse2695 Alliance HPLC and a 2489UV/Vis detector, and a detection wavelength of Oxytetracycline (OTC) and chlorotetracycline (CTC) of 355 nm. The detection conditions are as follows: the temperature of the chromatographic column is 35 ℃, the injection volume is 20 mu L, and the flow rate is 1 mL/min-1. Mobile phase composition: 80% of the solution contains 0.01 mol.L-1Oxalic acid in water, 20% acetonitrile.

Claims (3)

1. A method for the biological removal of tetracycline antibiotics comprising the steps of:
(1) seed culture: culturing Bacillus clausii Bacillus clausii T to obtain a first-stage Bacillus clausii seed; culturing the first-stage seeds of the bacillus clausii to obtain second-stage seeds of the bacillus clausii;
culturing Bacillus amyloliquefaciens HM-618, CGMCC7097, abbreviated as HM-618 to obtain first-grade seeds of HM-618; culturing the first-level seeds of HM-618 to obtain second-level seeds of HM-618;
(2) removing: adding 70-80mL of water containing tetracycline antibiotics into 20-30mL of fermentation medium according to a proportion to prepare degradation liquid; inoculating the secondary seed of the bacillus clausii obtained in the step (1) and the secondary seed of HM-618 into 100mL of degradation liquid to ensure that the total initial OD6000.15-0.23, the initial inoculation of the second-level seed of Bacillus clausii and the second-level seed of HM-618The seed ratio is 1: 1; fermenting for 96-120h at the rotating speed of 200-220 rpm and the temperature of 36-38 ℃.
2. The method of claim 1, wherein the fermentation medium is formulated as: 55-65g/L of glucose; 3-8g/L of yeast extract powder; 3-8g/L of peptone; 3-8g/L of NaCl; KCl 0.3-0.8 g/L; k2HPO41-5 g/L;KH2PO41-5g/L;MgSO4·7H2O 0.3-0.8g/L;FeSO4·7H2O(0.5-1.5)×10-3g/L;CuSO4·5H2O(0.5-1.5)×10-5g/L;MnSO4(5-8)×10-5g/L;ZnSO4·7H2O(0.5-1.5)×10-3g/L; the balance of water.
3. The method of claim 1, wherein said tetracycline antibiotics are oxytetracycline and chlortetracycline.
CN201911168281.0A 2019-11-25 2019-11-25 Method for biologically removing tetracycline antibiotics Active CN110904002B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911168281.0A CN110904002B (en) 2019-11-25 2019-11-25 Method for biologically removing tetracycline antibiotics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911168281.0A CN110904002B (en) 2019-11-25 2019-11-25 Method for biologically removing tetracycline antibiotics

Publications (2)

Publication Number Publication Date
CN110904002A true CN110904002A (en) 2020-03-24
CN110904002B CN110904002B (en) 2022-04-29

Family

ID=69819313

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911168281.0A Active CN110904002B (en) 2019-11-25 2019-11-25 Method for biologically removing tetracycline antibiotics

Country Status (1)

Country Link
CN (1) CN110904002B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110699408A (en) * 2019-10-21 2020-01-17 天津大学 Method for improving surfactant yield by mixed fermentation

Citations (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101096650A (en) * 2007-06-11 2008-01-02 北京联合大学 One strain clausius bacillus mutant and fermentation production of alkaline pectic enzyme
TW200804594A (en) * 2005-12-14 2008-01-16 Novozymes As Polypeptides having antimicrobial activity and polynucleotides encoding same
EP1929087A2 (en) * 2005-09-01 2008-06-11 Seldon Technologies, Inc Large scale manufacturing of nanostructured material
CN101748078A (en) * 2008-12-05 2010-06-23 农业药物毒物试验所 Novel Bacillus amyloliquefaciens strain and application thereof
CN101935633A (en) * 2010-07-06 2011-01-05 中国科学院南京土壤研究所 Bacillus amyloliquefacien BZ6-1 strain for producing biosurfactant and application thereof in oil sludge elution
CN102630163A (en) * 2009-09-21 2012-08-08 皇家霍洛威和贝德福德新学院 Bacterial spore having therapeutic agent adsorbed on its surface
CN102719383A (en) * 2012-06-29 2012-10-10 武汉工业学院 Bacillus amyloliquefaciens, inoculant and application thereof
CN103013960A (en) * 2012-12-21 2013-04-03 青岛蔚蓝生物集团有限公司 Alkaline protease and recombinant expression engineering bacterium thereof
CN103589655A (en) * 2013-05-20 2014-02-19 山西农业大学 Preparation method for Bacillus amyloliquefaciens HRH 317 and antibacterial substances thereof
WO2014100777A2 (en) * 2012-12-20 2014-06-26 Rajiv Bhushan Antimicrobial compositions
CN105018373A (en) * 2015-07-08 2015-11-04 青岛蔚蓝生物集团有限公司 Bacillus clausii with high yield of alkaline protease
CN105121622A (en) * 2013-02-06 2015-12-02 恩威拉有限责任公司 Dried spore germinative compound mixtures
CN105132304A (en) * 2015-07-06 2015-12-09 青岛蔚蓝生物集团有限公司 Gemma generation defective Bacillus clausii for high yield of alkali protease
CN105602884A (en) * 2016-02-17 2016-05-25 天津师范大学 Method for alleviating toxicity of heavy metal cadmium to root system growth-promoting bacteria
CN105602883A (en) * 2016-02-17 2016-05-25 天津师范大学 Method for utilizing cerium chloride to relieve toxicity on root system growth-promoting bacteria caused by heavy metal cadmium
CN105695543A (en) * 2016-01-22 2016-06-22 南京农业大学 Production method of bio-surfactin
CN106011035A (en) * 2016-08-04 2016-10-12 大连知微生物科技有限公司 Bacillus amyloliquefaciens for producing surfactin, and application thereof
CN106635869A (en) * 2016-09-26 2017-05-10 江南大学 Method for producing surfactin by applying bacillus amyloliquefaciens
CN107058156A (en) * 2016-12-27 2017-08-18 北京市农林科学院 Tetracycline antibiotics degradation bacteria strains, the microbial inoculum containing the bacterial strain and its application
CN110669811A (en) * 2019-10-21 2020-01-10 天津大学 Method for improving surfactant yield
CN110699408A (en) * 2019-10-21 2020-01-17 天津大学 Method for improving surfactant yield by mixed fermentation
CN111246865A (en) * 2017-07-12 2020-06-05 同生运营公司 Microorganisms programmed to produce immunomodulators and anticancer therapeutics in tumor cells

Patent Citations (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1929087A2 (en) * 2005-09-01 2008-06-11 Seldon Technologies, Inc Large scale manufacturing of nanostructured material
TW200804594A (en) * 2005-12-14 2008-01-16 Novozymes As Polypeptides having antimicrobial activity and polynucleotides encoding same
CN101096650A (en) * 2007-06-11 2008-01-02 北京联合大学 One strain clausius bacillus mutant and fermentation production of alkaline pectic enzyme
CN101748078A (en) * 2008-12-05 2010-06-23 农业药物毒物试验所 Novel Bacillus amyloliquefaciens strain and application thereof
CN102630163A (en) * 2009-09-21 2012-08-08 皇家霍洛威和贝德福德新学院 Bacterial spore having therapeutic agent adsorbed on its surface
CN101935633A (en) * 2010-07-06 2011-01-05 中国科学院南京土壤研究所 Bacillus amyloliquefacien BZ6-1 strain for producing biosurfactant and application thereof in oil sludge elution
CN102719383A (en) * 2012-06-29 2012-10-10 武汉工业学院 Bacillus amyloliquefaciens, inoculant and application thereof
WO2014100777A2 (en) * 2012-12-20 2014-06-26 Rajiv Bhushan Antimicrobial compositions
US20150342848A1 (en) * 2012-12-20 2015-12-03 Rajiv Bhushan Antimicrobial compositions
CN103013960A (en) * 2012-12-21 2013-04-03 青岛蔚蓝生物集团有限公司 Alkaline protease and recombinant expression engineering bacterium thereof
CN105121622A (en) * 2013-02-06 2015-12-02 恩威拉有限责任公司 Dried spore germinative compound mixtures
CN103589655A (en) * 2013-05-20 2014-02-19 山西农业大学 Preparation method for Bacillus amyloliquefaciens HRH 317 and antibacterial substances thereof
CN105132304A (en) * 2015-07-06 2015-12-09 青岛蔚蓝生物集团有限公司 Gemma generation defective Bacillus clausii for high yield of alkali protease
CN105018373A (en) * 2015-07-08 2015-11-04 青岛蔚蓝生物集团有限公司 Bacillus clausii with high yield of alkaline protease
CN105695543A (en) * 2016-01-22 2016-06-22 南京农业大学 Production method of bio-surfactin
CN105602884A (en) * 2016-02-17 2016-05-25 天津师范大学 Method for alleviating toxicity of heavy metal cadmium to root system growth-promoting bacteria
CN105602883A (en) * 2016-02-17 2016-05-25 天津师范大学 Method for utilizing cerium chloride to relieve toxicity on root system growth-promoting bacteria caused by heavy metal cadmium
CN106011035A (en) * 2016-08-04 2016-10-12 大连知微生物科技有限公司 Bacillus amyloliquefaciens for producing surfactin, and application thereof
CN106635869A (en) * 2016-09-26 2017-05-10 江南大学 Method for producing surfactin by applying bacillus amyloliquefaciens
CN107058156A (en) * 2016-12-27 2017-08-18 北京市农林科学院 Tetracycline antibiotics degradation bacteria strains, the microbial inoculum containing the bacterial strain and its application
CN111246865A (en) * 2017-07-12 2020-06-05 同生运营公司 Microorganisms programmed to produce immunomodulators and anticancer therapeutics in tumor cells
CN110669811A (en) * 2019-10-21 2020-01-10 天津大学 Method for improving surfactant yield
CN110699408A (en) * 2019-10-21 2020-01-17 天津大学 Method for improving surfactant yield by mixed fermentation

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
CHUN-XIAO LIU 等: "Bio-removal of tetracycline antibiotics under the consortium with probiotics Bacillus clausii T and Bacillus amyloliquefaciens producing biosurfactants", 《SCIENCE OF THE TOTAL ENVIRONMENT》 *
GABRIELLE RIPERT 等: "Secreted Compounds of th Inhibit the Cytotoxic Effects Induced by Clostridium difficile and e Probiotic Bacillus clausii Strain O/C Bacillus cereus Toxins", 《ANTIMICROBIAL AGENTS AND CHEMOTHERAPY》 *
XIU-XIU KONG 等: "The biodegradation of cefuroxime, cefotaxime and cefpirome by the synthetic consortium with probiotic Bacillus clausii and investigation of their potential biodegradation pathways", 《SCIENCE OF THE TOTAL ENVIRONMENT》 *
唐敏慧: "解淀粉芽抱杆菌HM618产表面活性素发酵优化和基因组分析", 《中国优秀硕士学位论文全文数据库(电子期刊)工程科技I辑》 *
姜聪 等: "通过敲除解淀粉芽胞杆菌表面活性剂基因促进S-腺苷甲硫氨酸合成", 《食品与发酵工业》 *
孔秀秀: "益生菌Bacillus clausii对头袍类抗生素的降解研究", 《中国优秀硕士学位论文全文数据库(电子期刊)工程科技I辑》 *
张冬青 主编: "《生物药物分析》", 31 August 2008, 华南理工大学出版社 *
张抗怀 主编: "《全科用药指南》", 31 March 2017, 西安交通大学出版社 *
李颂硕: "解淀粉芽抱杆菌s3-1的田间应用", 《中国优秀硕士学位论文全文数据库(电子期刊)》 *
甘永琦等: "克劳芽孢杆菌体外益生特性初步研究", 《药物生物技术》 *
范瑞梅 等: "克劳氏芽孢杆菌(Bacillus clausii S-4) 吸附Zn2+的研究", 《环境工程学报》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110699408A (en) * 2019-10-21 2020-01-17 天津大学 Method for improving surfactant yield by mixed fermentation

Also Published As

Publication number Publication date
CN110904002B (en) 2022-04-29

Similar Documents

Publication Publication Date Title
Liu et al. Bio-removal of tetracycline antibiotics under the consortium with probiotics Bacillus clausii T and Bacillus amyloliquefaciens producing biosurfactants
Maniyam et al. Decolourization and biodegradation of azo dye methyl red by Rhodococcus strain UCC 0016
Jun et al. Isolation and identification of a di-(2-ethylhexyl) phthalate-degrading bacterium and its role in the bioremediation of a contaminated soil
Li et al. Immobilization of Rhodococcus rhodochrous BX2 (an acetonitrile-degrading bacterium) with biofilm-forming bacteria for wastewater treatment
Zhang et al. Performance of enhanced biological SBR process for aniline treatment by mycelial pellet as biomass carrier
US11584913B2 (en) Pseudomonas aeruginosa with monomethylamine degradability and application thereof
CN106947724B (en) Method for increasing dissolved oxygen of gamma-polyglutamic acid fermentation liquor
JP2017502677A (en) Sporolactobacillus terae and its use
Gu et al. Isolation of phylogenetically diverse nonylphenol ethoxylate-degrading bacteria and characterization of their corresponding biotransformation pathways
Corso et al. Bioremediation of direct dyes in simulated textile effluents by a paramorphogenic form of Aspergillus oryzae
CN103468609B (en) Polycyclic aromatic hydrocarbon and organic tin combined pollution treatment fungicide as well as preparation method and application thereof
CN110724654B (en) Pseudomonas aeruginosa for producing 5-hydroxymethyl-2-furancarboxylic acid and application thereof
CN104099274A (en) Cupriavidus sp. IDO capable of aerobic degrading indole and application thereof
CN110904002B (en) Method for biologically removing tetracycline antibiotics
US6383797B1 (en) Bacterial consortium EBC1000 and a method using the bacterial consortium EBC1000 for remedying biologically recalcitrant toxic chemicals contained in industrial wastewater, waste materials and soils
Lin et al. A biosurfactant-producing yeast Rhodotorula sp. CC01 utilizing landfill leachate as nitrogen source and its broad degradation spectra of petroleum hydrocarbons
CN103045496A (en) Preparation method of high-efficient degrading bacterium agent for phthalate ester environmental hormone
Wu et al. Kocuria rosea HN01, a newly alkaliphilic humus-reducing bacterium isolated from cassava dreg compost
CN103184177B (en) 6-aminopenicillanic acid degrading bacterium and screening method thereof
CN106591172B (en) A kind of Rhodococcus ruber PTA-2 and its immobilization and application
CN115491338B (en) Chemical intermediate degrading strain and application thereof in wastewater treatment
Li et al. Enhanced biodegradation of methyl tert-butyl-ether by a microbial consortium
Khan et al. Application of microbial biofilms in biocatalysis and biodegradation
Mukhtar et al. Kinetics of the biosorptive removal of chromium from water using mycelial biomass of Aspergillus oryzae
Shi et al. Mineralization and kinetics of reactive Brilliant Red X-3B by a combined anaerobic–aerobic bioprocess inoculated with the coculture of fungus and bacterium

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant